Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ONCT Oncternal Therapeutics Inc

0,5266

0,00 (0,00%)

21 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Oncternal Therapeutics (NASDAQ:ONCT)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Oncternal Therapeutics Charts.

Oncternal Therapeutics (NASDAQ:ONCT)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Oncternal Therapeutics Charts.

News Oncternal Therapeutics Inc

Form 8-K - Current report
Montag 25 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 6 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Dienstag 22 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Dienstag 15 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 12 September 2024 (4 Monate vor) • Edgar (US Regulatory)

Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives
Donnerstag 12 September 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 8 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 8 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Freitag 8 März 2024 (10 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Donnerstag 7 März 2024 (11 Monate vor) • Edgar (US Regulatory)

Weitere Oncternal Therapeutics Inc News-Artikel

S&P ASX 200 Futures Aoni...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen